Kloramfenikol Santen

Chloramphenicol, the active ingredient in Kloramfenikol Santen, is an amphenicol antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial conjunctivitis and other bacterial eye infections in patients requiring topical therapy.

GNH USA supplies Kloramfenikol Santen as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Chloramphenicol is used to treat bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load and alleviates redness, discharge and irritation. - Acute bacterial keratitis: eradicates causative organisms and promotes corneal healing. - Post‑operative ocular infection: prevents bacterial proliferation after eye surgery.

Chloramphenicol ophthalmic solution may cause local and systemic adverse reactions.

Common Side Effects: - Ocular irritation or burning sensation. - Redness of the conjunctiva. - Itching or mild discomfort. - Increased tearing or watery eyes. - Blurred vision temporarily. - Mild eyelid swelling.

Serious or Rare Side Effects: - Allergic contact dermatitis of the eyelid or peri‑ocular skin. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Aplastic anemia (systemic exposure, extremely rare). - Severe ocular inflammation or corneal ulceration. - Vision loss due to toxic keratitis. - Systemic hypersensitivity reactions.

When using Kloramfenikol Santen, consider the following precautions.

- Assess allergy history: avoid if known hypersensitivity to chloramphenicol or other amphenicols. - Avoid use in viral conjunctivitis: may worsen the condition. - Limit duration: typically not exceed 7 days to reduce resistance development. - Monitor for systemic absorption: especially in infants, compromised corneas, or prolonged use. - Use with caution in pregnancy: insufficient data, consult a physician before prescribing. - Store at room temperature: keep in the original container, protect from light and moisture.

Chloramphenicol ophthalmic solution can interact with other medications.

Major Interactions (Avoid): - Systemic chloramphenicol: additive risk of bone‑marrow suppression. - Topical aminoglycosides: increased risk of ocular toxicity. - Topical NSAIDs: may enhance corneal irritation.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of infection. - Concurrent ophthalmic antibiotics: possible antagonistic effects. - Contact lens wear: may reduce drug efficacy and increase irritation.